Literature DB >> 1631557

Crystal structure of transforming growth factor-beta 2: an unusual fold for the superfamily.

S Daopin1, K A Piez, Y Ogawa, D R Davies.   

Abstract

The transforming growth factors-beta (TGF-beta 1 through -beta 5) are a family of homodimeric cytokines that regulate proliferation and function in many cell types. Family members have 66 to 80% sequence identity and nine strictly conserved cysteines. A crystal structure of a member of this family, TGF-beta 2, has been determined at 2.1 angstrom (A) resolution and refined to an R factor of 0.172. The monomer lacks a well-defined hydrophobic core and displays an unusual elongated nonglobular fold with dimensions of approximately 60 A by 20 A by 15 A. Eight cysteines form four intrachain disulfide bonds, which are clustered in a core region forming a network complementary to the network of hydrogen bonds. The dimer is stabilized by the ninth cysteine, which forms an interchain disulfide bond, and by two identical hydrophobic interfaces. Sequence profile analysis of other members of the TGF-beta superfamily, including the activins, inhibins, and several developmental factors, imply that they also adopt the TGF-beta fold.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1631557     DOI: 10.1126/science.1631557

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  89 in total

1.  Anginex, a designed peptide that inhibits angiogenesis.

Authors:  A W Griffioen; D W van der Schaft; A F Barendsz-Janson; A Cox; H A Struijker Boudier; H F Hillen; K H Mayo
Journal:  Biochem J       Date:  2001-03-01       Impact factor: 3.857

2.  Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGF-beta ligand:receptor interactions.

Authors:  Thomas B Thompson; Teresa K Woodruff; Theodore S Jardetzky
Journal:  EMBO J       Date:  2003-04-01       Impact factor: 11.598

3.  The recombinant C-terminus of the human MUC2 mucin forms dimers in Chinese-hamster ovary cells and heterodimers with full-length MUC2 in LS 174T cells.

Authors:  Martin E Lidell; Malin E V Johansson; Matthias Mörgelin; Noomi Asker; James R Gum; Young S Kim; Gunnar C Hansson
Journal:  Biochem J       Date:  2003-06-01       Impact factor: 3.857

4.  Content and localization of myostatin in mouse skeletal muscles during aging, mechanical unloading and reloading.

Authors:  S Kawada; C Tachi; N Ishii
Journal:  J Muscle Res Cell Motil       Date:  2001       Impact factor: 2.698

5.  Active multilayered capsules for in vivo bone formation.

Authors:  S Facca; C Cortez; C Mendoza-Palomares; N Messadeq; A Dierich; A P R Johnston; D Mainard; J-C Voegel; F Caruso; N Benkirane-Jessel
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-16       Impact factor: 11.205

6.  Reply to Regarding the mechanism of action of a proposed peptide agonist of the bone morphogenetic protein receptor activin-like kinase 3.

Authors:  Hikaru Sugimoto; Valerie S LeBleu; Dattatreyamurty Bosukonda; Peter Keck; Gangadhar Taduri; Wibke Bechtel; Hirokazu Okada; William Carlson; Philippe Bey; Mary Rusckowski; Björn Tampe; Desiree Tampe; Keizo Kanasaki; Michael Zeisberg; Raghu Kalluri
Journal:  Nat Med       Date:  2013-07       Impact factor: 53.440

Review 7.  Structural Biology and Evolution of the TGF-β Family.

Authors:  Andrew P Hinck; Thomas D Mueller; Timothy A Springer
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-12-01       Impact factor: 10.005

Review 8.  The DAN family: modulators of TGF-β signaling and beyond.

Authors:  Kristof Nolan; Thomas B Thompson
Journal:  Protein Sci       Date:  2014-06-02       Impact factor: 6.725

9.  Nerve growth factor: structure/function relationships.

Authors:  R A Bradshaw; J Murray-Rust; C F Ibáñez; N Q McDonald; R Lapatto; T L Blundell
Journal:  Protein Sci       Date:  1994-11       Impact factor: 6.725

10.  Members of the DAN family are BMP antagonists that form highly stable noncovalent dimers.

Authors:  Chandramohan Kattamuri; David M Luedeke; Kristof Nolan; Scott A Rankin; Kenneth D Greis; Aaron M Zorn; Thomas B Thompson
Journal:  J Mol Biol       Date:  2012-10-09       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.